European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F., Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A., Hehlmann, R.
Published in Leukemia (01.04.2020)
Published in Leukemia (01.04.2020)
Get full text
Journal Article
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
Kalmanti, L, Saussele, S, Lauseker, M, Müller, M C, Dietz, C T, Heinrich, L, Hanfstein, B, Proetel, U, Fabarius, A, Krause, S W, Rinaldetti, S, Dengler, J, Falge, C, Oppliger-Leibundgut, E, Burchert, A, Neubauer, A, Kanz, L, Stegelmann, F, Pfreundschuh, M, Spiekermann, K, Scheid, C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R
Published in Leukemia (01.05.2015)
Published in Leukemia (01.05.2015)
Get full text
Journal Article
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
Pfirrmann, M, Baccarani, M, Saussele, S, Guilhot, J, Cervantes, F, Ossenkoppele, G, Hoffmann, V S, Castagnetti, F, Hasford, J, Hehlmann, R, Simonsson, B
Published in Leukemia (01.01.2016)
Published in Leukemia (01.01.2016)
Get full text
Journal Article
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
Steegmann, J L, Baccarani, M, Breccia, M, Casado, L F, García-Gutiérrez, V, Hochhaus, A, Kim, D-W, Kim, T D, Khoury, H J, Le Coutre, P, Mayer, J, Milojkovic, D, Porkka, K, Rea, D, Rosti, G, Saussele, S, Hehlmann, R, Clark, R E
Published in Leukemia (01.08.2016)
Published in Leukemia (01.08.2016)
Get full text
Journal Article
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
Koschmieder, S, Mughal, T I, Hasselbalch, H C, Barosi, G, Valent, P, Kiladjian, J-J, Jeryczynski, G, Gisslinger, H, Jutzi, J S, Pahl, H L, Hehlmann, R, Maria Vannucchi, A, Cervantes, F, Silver, R T, Barbui, T
Published in Leukemia (01.05.2016)
Published in Leukemia (01.05.2016)
Get full text
Journal Article
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
Hoffmann, V S, Baccarani, M, Hasford, J, Lindoerfer, D, Burgstaller, S, Sertic, D, Costeas, P, Mayer, J, Indrak, K, Everaus, H, Koskenvesa, P, Guilhot, J, Schubert-Fritschle, G, Castagnetti, F, Di Raimondo, F, Lejniece, S, Griskevicius, L, Thielen, N, Sacha, T, Hellmann, A, Turkina, A G, Zaritskey, A, Bogdanovic, A, Sninska, Z, Zupan, I, Steegmann, J-L, Simonsson, B, Clark, R E, Covelli, A, Guidi, G, Hehlmann, R
Published in Leukemia (01.06.2015)
Published in Leukemia (01.06.2015)
Get full text
Journal Article
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
Hanfstein, B, Müller, M C, Hehlmann, R, Erben, P, Lauseker, M, Fabarius, A, Schnittger, S, Haferlach, C, Göhring, G, Proetel, U, Kolb, H-J, Krause, S W, Hofmann, W-K, Schubert, J, Einsele, H, Dengler, J, Hänel, M, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Branford, S, Hughes, T P, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Saußele, S, Hochhaus, A
Published in Leukemia (01.09.2012)
Published in Leukemia (01.09.2012)
Get full text
Journal Article
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A, Hehlmann, R
Published in Leukemia (01.03.2017)
Published in Leukemia (01.03.2017)
Get full text
Journal Article
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
Schütz, C, Inselmann, S, Sausslele, S, Dietz, C T, Müller, M C, Eigendorff, E, Brendel, C A, Metzelder, S K, Brümmendorf, T H, Waller, C, Dengler, J, Goebeler, M E, Herbst, R, Freunek, G, Hanzel, S, Illmer, T, Wang, Y, Lange, T, Finkernagel, F, Hehlmann, R, Huber, M, Neubauer, A, Hochhaus, A, Guilhot, J, Xavier Mahon, F, Pfirrmann, M, Burchert, A
Published in Leukemia (01.04.2017)
Published in Leukemia (01.04.2017)
Get full text
Journal Article
Harmonization of molecular monitoring of CML therapy in Europe
Müller, M C, Cross, N C P, Erben, P, Schenk, T, Hanfstein, B, Ernst, T, Hehlmann, R, Branford, S, Saglio, G, Hochhaus, A
Published in Leukemia (01.11.2009)
Published in Leukemia (01.11.2009)
Get full text
Journal Article
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S
Published in Leukemia (01.06.2016)
Published in Leukemia (01.06.2016)
Get full text
Journal Article
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib
Hanfstein, B, Shlyakhto, V, Lauseker, M, Hehlmann, R, Saussele, S, Dietz, C, Erben, P, Fabarius, A, Proetel, U, Schnittger, S, Krause, S W, Schubert, J, Einsele, H, Hänel, M, Dengler, J, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Hofmann, W-K, Hochhaus, A, Müller, M C
Published in Leukemia (01.10.2014)
Published in Leukemia (01.10.2014)
Get full text
Journal Article
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
Marchetti, M, Barosi, G, Cervantes, F, Birgegård, G, Griesshammer, M, Harrison, C, Hehlmann, R, Kiladjian, J-J, Kröger, N, McMullin, M F, Passamonti, F, Vannucchi, A, Barbui, T
Published in Leukemia (01.04.2017)
Published in Leukemia (01.04.2017)
Get full text
Journal Article
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
HOCHHAUS, A, KREIL, S, GSCHAIDMEIER, H, DRUKER, B. J, HEHLMANN, R, CORBIN, A. S, ROSEE, P. La, MÜLLER, M. C, LAHAYE, T, HANFSTEIN, B, SCHOCH, C, CROSS, N. C. P, BERGER, U
Published in Leukemia (01.11.2002)
Published in Leukemia (01.11.2002)
Get full text
Journal Article
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia
Burchert, A, Saussele, S, Eigendorff, E, Müller, M C, Sohlbach, K, Inselmann, S, Schütz, C, Metzelder, S K, Ziermann, J, Kostrewa, P, Hoffmann, J, Hehlmann, R, Neubauer, A, Hochhaus, A
Published in Leukemia (01.06.2015)
Published in Leukemia (01.06.2015)
Get full text
Journal Article